Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Hoos

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Human Pathology|February 28, 2003
Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysisAlexander Stojadinovic, Axel Hoos, Aviram Nissan, et al.
Journal of the National Cancer Institute|September 10, 2010
Improved endpoints for cancer immunotherapy trialsAxel Hoos, Alexander M M Eggermont, Sylvia Janetzki, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 16, 2003
Adrenocortical adenoma and carcinoma: histopathological and molecular comparative analysisAlexander Stojadinovic, Murray F Brennan, Axel Hoos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
p63 expression profiles in human normal and tumor tissuesCharles J Di Como, Marshall J Urist, Irina Babayan, et al.
Science Translational Medicine|November 11, 2011
Harmonization of immune biomarker assays for clinical studiesSjoerd H van der Burg, Michael Kalos, Cécile Gouttefangeas, et al.
Cancer Immunology, Immunotherapy : CII|March 5, 2009
Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine ConsortiumCedrik Michael Britten, Sylvia Janetzki, Leah Ben-Porat, et al.
Journal of Translational Medicine|July 13, 2011
A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocolsSebastian Attig, Leah Price, Sylvia Janetzki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery aloneAviram Nissan, Alexander Stojadinovic, Jinru Shia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: a comprehensive analysisAxel Hoos, Aviram Nissan, Alexander Stojadinovic, et al.
The American Journal of Pathology|January 12, 2002
Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarraysAxel Hoos, Alexander Stojadinovic, Bhuvanesh Singh, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Human Pathology|February 28, 2003
Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysisAlexander Stojadinovic, Axel Hoos, Aviram Nissan, et al.
Journal of the National Cancer Institute|September 10, 2010
Improved endpoints for cancer immunotherapy trialsAxel Hoos, Alexander M M Eggermont, Sylvia Janetzki, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 16, 2003
Adrenocortical adenoma and carcinoma: histopathological and molecular comparative analysisAlexander Stojadinovic, Murray F Brennan, Axel Hoos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
p63 expression profiles in human normal and tumor tissuesCharles J Di Como, Marshall J Urist, Irina Babayan, et al.
Science Translational Medicine|November 11, 2011
Harmonization of immune biomarker assays for clinical studiesSjoerd H van der Burg, Michael Kalos, Cécile Gouttefangeas, et al.
Cancer Immunology, Immunotherapy : CII|March 5, 2009
Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine ConsortiumCedrik Michael Britten, Sylvia Janetzki, Leah Ben-Porat, et al.
Journal of Translational Medicine|July 13, 2011
A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocolsSebastian Attig, Leah Price, Sylvia Janetzki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery aloneAviram Nissan, Alexander Stojadinovic, Jinru Shia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: a comprehensive analysisAxel Hoos, Aviram Nissan, Alexander Stojadinovic, et al.
The American Journal of Pathology|January 12, 2002
Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarraysAxel Hoos, Alexander Stojadinovic, Bhuvanesh Singh, et al.
Pageof 8